We're redesigning the DORA website, and we need your help. Please take our survey now!

Text Size
Increase text size
Increase text size

State Board of Pharmacy

Chris M. Gassen, Program Director

Consumer Protection is Our Mission.

The Colorado State Board of Pharmacy (“Board”) regulates pharmacists, pharmacy interns, in-state and nonresident pharmacies, in-state and out-of-state prescription drug wholesalers, satellite pharmacies, specialized prescription drug outlets, other outlets, and limited licenses.  The Board consists of five pharmacist members and two public members.  The Board upholds DORA’s mission of consumer protection by licensing qualified applicants, investigating complaints, and enforcing disciplinary actions against those who violate the Pharmacists, Pharmacy Businesses and Pharmaceuticals Act and the Board’s Rules.  The Board works in conjunction with the Federal Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Colorado Pharmacists Society, RxPlus Pharmacies, and the Colorado Retail Counsel.

News  Items


Recent Legislation


HB14-1283 Modify Prescription Drug Monitoring Program 


HB14-1283 makes the following several modifications to the electronic prescription drug monitoring program including:

• The dissemination of automatic reports to prescribers and pharmacies when a patient meets a defined threshold that takes into account the number of prescribers and pharmacies visited within a certain timeframe. Reports will start in September 2014.

• Allows a prescribing practitioner or a pharmacist to delegate authority to access the database to up to 3 designees acting for the practitioner or pharmacist, and requires each designee to register with the program under a sub-account of the practitioner or pharmacist. Delegated Access will start in January 2015.

• Requires prescribing practitioners and pharmacists to register and create user accounts with the program by a deadline established by the Director of the Division of Professions and Occupations.Those deadlines are:

• Pharmacists and DEA-registered Advanced Practice Nurses: September 30, 2014

• DEA-registered Dentists, Veterinarians, Optometrists and Podiatrists: October 31, 2014

• DEA-registered Medical Board licensees: November 30, 2014

• Allows the Colorado Department of Public Health and Environment (CDPHE) to access data from the PDMP for public health research. CDPHE access will begin in the Fall 2014.

• Allows an out-of-state pharmacist to obtain Colorado PDMP data in connection with a current patient to whom the pharmacist is dispensing a controlled substance or is providing clinical patient care services. This ability to obtain such data is already available.

• Adds individual pharmacies as an eligible subject for information requests by law enforcement officials if the request for information is accompanied by a court order or subpoena beginning immediately.

• Allows federally owned and operated pharmacies to submit data to the database beginning immediately.

• Authorizes the executive director of the department of regulatory agencies to create a prescription drug monitoring program task force, or to request assistance from the team assembled by the governor's office to develop a plan to reduce prescription drug abuse, to study the program and make recommendations to the executive director on ways to ensure that the program is effective at reducing prescription drug abuse and misuse. The Executive Director has requested the Governor’s Consortium for Prescription Drug Abuse serve as the taskforce.

Together, these modifications to the PDMP will require updating the online PDMP system and notifying prescribers and dispensers as well as those who receive delegated access to the PDMP of the provisions of this bill.



HB14-1083 Acute Treatment Units Stock Medications 


HB14-1083   Acute treatment units (ATU) provide medically supervised behavioral health treatment services to individuals who suffer from psychiatric disorders. Current law does not allow an ATU to have an onsite stock of medications. The bill allows an ATU to procure, store, order, dispense, and administer prescription medications and to receive a supply of emergency kits or starter doses from a registered prescription drug outlet or licensed hospital for patient treatment. Implementation of this bill will require rulemaking by the State Board of Pharmacy, the updating of applications and outreach. Rulemaking will occur on August 21, 2014.




HB14-1290 Telepharmacy Remote Pharmacy Outlet


HB14-1290 adds to the definition of "other outlet" under the statutes governing the practice of pharmacy a telepharmacy outlet located more than 20 miles from the nearest pharmacy. A prescribing practitioner cannot own a telepharmacy, and the State Board of Pharmacy is authorized to impose additional telepharmacy ownership restrictions by rule. Implementation of this bill will require rulemaking by the State Board of Pharmacy and the updating of applications. It is anticipated there will be a very small number of telepharmacy registering as an “other outlet.”




SB14-095 Pharmacies Compounding Drugs For Hospitals 


SB14-095 Under previous law, a prescription drug outlet could only distribute compounded drugs for office use to practitioners who are authorized to prescribe drugs. The bill allows a prescription drug outlet to also distribute compounded drugs to a hospital located in Colorado.




HB14-1173 Sunset Controlled Substances Abuse Act


HB14-1173 extends the “Colorado Licensing of Controlled Substances Act” (act) until 2025. While the provisions of this bill fall under the jurisdiction of the Colorado Department of Human Services (CDHS), a portion of the act affects the Prescription Drug Monitoring Program which is administered by DORA’s Division of Professions and Occupations (DPO). Implementation of this bill will primarily occur at CDHS, however DPO is tasked with updating the PDMP online system. The updates required of the PDMP system and rules are also required by HB14-1283 which establishes a deadline of January 1, 2015.

That’s not all! Legislation was passed this year that relates to healthcare providers such as medical records, hepatitis C screenings, and crimes against elders. Click here to learn more about these important changes.


Attention all Colorado-licensed Pharmacists and DEA-registered Prescribing Practitioners

Pursuant to House Bill 14-1283 (now CRS 12-42.5-403), all Colorado licensed prescribing practitioners who possess an individual DEA registration and all Colorado licensed pharmacists are required to register an individual user account with Colorado's Prescription Drug Monitoring Program (PDMP).  To this end, the Director of the Division of Professions and Occupations has assigned the following due dates for each corresponding profession for this purpose.

  • Pharmacists and DEA-registered Advanced Practice Nurses:  September 30, 2014
  • DEA-registered Dentists, Veterinarians, Optometrists and Podiatrists:  October 31, 2014
  • DEA-registered Medical Board licensees:  November 30, 2014

While all pharmacists and DEA-registered prescribing practitioners may and are certainly encouraged to register a user account with the PDMP at anytime between now and before September 30th, these are the respective due dates for each profession.

To begin this process, please utilize the following link for more information about the PDMP and to begin creating a PDMP account. 

While account creation normally takes less than 5 minutes, should you have questions regarding how to register a PDMP account, please contact the PDMP Help Desk at 1-855-263-6403.

PDMP Task Force Letter from Barbara J. Kelley to The Colorado Consortium to Reduce Prescription Drug Abuse


New! Healthcare Professions Profile (HPPP) Requirement

  • Creating and maintaining a Healthcare Professions Profile is now a requirement (SB 13-026).
  • Healthcare Professions Profiles must be updated within 30 days of a change or reportable event.
  • Click here to create/update your Healthcare Professions Profile.
  • Click here for more information on the Healthcare Professions Profile Program.

Colorado State Board of Pharmacy - Practice of Pharmacy Webinar and Review of New Pharmacy Rules

Guest Speaker: Jeannine Dickerhofe, RPh, MS President, State Board of Pharmacy

This is an opportunity for pharmacists, pharmacy interns, pharmacy technicians, and other interested parties to review the Colorado State Board of Pharmacy Laws and Rules concerning the practice of pharmacy in Colorado.  Please remember:  This is your chance to ask us lots of questions!  The pharmaceutical inspectors will present the webinar.
This webinar will also include an interview with Jeannine Dickerhofe, RPh, MS,  the President of the State Board of Pharmacy.  Ms. Dickerhofe has taken an active and formative role in the practice of pharmacy throughout her career.  Topics for discussion will include the work and mission of the Board of Pharmacy, the current state of pharmacy practice, and Ms. Dickerhofe’s views concerning the future of pharmacy practice.
No C.E.U. will be available for this class.

  • Date: Wednesday, February 11, 2015
  • Time: 9:00 - 11:00 a.m.

The following link can be used to register for this webinar.  You will receive a confirmation email with further information.

Reserve your Webinar Seat Now at: https://www.gotomeeting.com/register/545388504

System Requirements:

PC-Based attendee requirements: Windows 8, 7, Vista, XP or 2003 Server

Macintosh-Based attendee requirements: Mac OS X 10.6 or newer

Mobile attendee requirements: iPhone, iPad, Android phone or Android tablet


Notice of Rule Making Hearing and Proposed Amendments to Pharmacy Board Rules


Board Adopts New Opioid Policy

The Board adopted a new policy for the Prescribing and Dispensing of Opioids, part of a collaborative effort with the Quad-Regulator Boards as one part of a statewide solution to reduce prescription drug abuse and misuse.  The Quad-Regulator Boards include the Colorado Medical Board, the Colorado State Board of Nursing, the Colorado Board of Pharmacy, and the Colorado State Board of Dental Examiners, facilitated by the Nurse-Physician Advisory Task Force for Colorado Healthcare (NPATCH).  Other boards that license prescribers of controlled substances also adopted the policy including the State Board of Optometry and the Colorado Podiatry Board while the State Board of Veterinary Medicine endorsed the policy. 
The development of a joint policy by multiple regulatory boards is a first.  For that reason, the policy was drafted through an open process that allowed for full consideration of stakeholder views through multiple public meetings from February to July 2014.
To view the policy that was unanimously adopted by the Quad-Regulators and other boards, please click here.  


Timeline for Quad-Regulator Opioid Policy

To provide guidance to prescribers and dispensers of opioids, the Quad-Regulator Boards at DORA are collaborating to draft a joint policy as one part of a statewide solution to reduce prescription drug abuse and misuse.  The Quad-Regulator Boards include the Colorado Medical Board, the Colorado State Board of Nursing, the Colorado Board of Pharmacy, and the Colorado State Board of Dental Examiners, facilitated by the Nurse-Physician Advisory Task Force for Colorado Healthcare (NPATCH).  The development of a joint policy by multiple regulatory boards is a first, so the Quad-Regulators are committed to an open process and timeline that allows for full consideration of stakeholder views.To view the policy that will be circulated for Board review and adoption, please click here. Comments and questions may be referred to Cory Everett at cory.everett@state.co.us.

Summer 2013

Separately, Quad-Boards developed policies and/or principles for prescribing and dispensing opioids at Board meetings and stakeholder meetings.

September 2013

Quad-Regulator Conference: Quad Boards met jointly to consider separate policies plus policies from other jurisdictions.

Oct-Dec 2013

Quad-Board Presidents (or their delegates) worked together to merge the four separate policies and practices from other jurisdictions and created first draft of Joint Policy.

January 2014

Legal and science review of draft policy.

February 2014

Draft policy dated 2/20.  Medical Board meetings 2/20 and 2/25.

March 2014

Revised draft dated 3/3.  Pharmacy Board meeting 3/20.  Quad-Stakeholder meeting 3/24.

April 2014

Quad-Board Presidents (or their delegates) worked together to incorporate comments.  Revised draft dated 4/3.  Quad-Stakeholder meeting 4/16.  Dental Board meeting 4/16.  Nursing Board meeting 4/22.



May 2014

Quad-Board Presidents (or their delegates) to work together to incorporate comments.  Revised draft anticipated by 5/16.  Medical Board meeting 5/22.  Quad-Stakeholder meeting anticipated week of 5/26.

June 2014

Deadline for comments on revised draft policy 6/6.  NPATCH meeting 6/6.  Quad-Board Presidents (or their delegates) work together to incorporate comments.  Anticipated first Board vote on policy -- Medical 6/19.

July 2014

Anticipated Board votes on policy -- Pharmacy 7/17, Nursing 7/22, and Dental 7/24.




 Changes to Midwives Statute that Affect Pharmacy

Senate Bill 11-088, which was signed into law in 2011, created two authorities for direct-entry midwives giving the registrants the ability to obtain and administer certain medications and intravenous fluids. The licensees can opt to have one or the other of the authorities or both.

Registrants with the medication authority, which is designated as "MWA" on their license card, can obtain and administer only the following drugs:

  1. Vitamin K1 (phylloquinone, phytonadione);
  2. Rho D immune globulin;
  3. Oxytocin (Pitocin);
  4. Methylergonovine (Methergine);
  5. Misoprostol (Cytotec);
  6. Erythromycin Ophthalmic Ointment.

Registrants with the authority to obtain and administer certain intravenous fluids are designated by "MIV" on their license card. These individuals can obtain and administer only the following intravenous fluids:

  1. 0.9% sodium chloride in sterile water; and
  2. Lactated Ringer's solution (LR).

Please be aware that a direct-entry midwife may have one, both, or none of these authorities. Please verify the midwife's license care prior to distributing any of the above-listed drugs to ensure the individual has the proper authority. This information is also available here.

For Your Information (FYI)....

Registration bulletins for NAPLEX and MPJE can now be downloaded from the National Association of Boards of Pharmacy (NABP) website,and registration forms can be requested online!

The State of Colorado does not register/certify or license Pharmacy Technicians. For information regarding Pharmacy Technician Certification, please visit the Pharmacy Technician Certification Board online.


Legislation passed during the Legislative Session impacts the Division of Professions and Occupations. Please review the program's Laws, Rules and Policies web page to learn of any changes due to legislation.

Adobe Acrobat Reader is required in order to view and print many of these materials. If you do not have Adobe Acrobat Reader, download the latest free version directly from the Adobe website, or convert a document to text.


facebook twitter


1560 Broadway, Suite 1350, Denver, CO 80202 Email
(303) 894-7800 - Phone (303) 894-7693 - Fax